{"id":"W4235223714","doi":"10.1200/jco.2021.39.15_suppl.5504","title":"Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients (pts) with platinum-agnostic ovarian cancer: Final analysis.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Bevacizumab; Ovarian cancer; Internal medicine; Adverse effect; Cancer; Sorafenib; Cohort; Gastroenterology; Oncology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00115301,0.0005636737,0.0009126681,0.0004611799,0.0001929313,0.0007906971,0.0004691487,0.0005453481,0.002019685],"category_scores_gemma":[0.0008908878,0.0003539741,0.001535802,0.0005307376,0.0002689301,0.0003718113,0.0002961264,0.0007058642,0.0003810806],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001143369,"about_ca_system_score_gemma":0.0008504097,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00120513,"about_ca_topic_score_gemma":0.003197978,"domain_scores_codex":[0.9995833,0.0001568445,0.00003678376,0.00007671177,0.00007892353,0.00006747804],"domain_scores_gemma":[0.9995965,0.00009525989,0.0001076637,0.00003043815,0.00004464051,0.0001253842],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5533986,0.008011489,0.1265694,0.002815193,0.01005923,0.001486676,0.0003982486,0.007987428,0.04014749,0.0003536648,0.004658694,0.244114],"study_design_scores_gemma":[0.1561659,0.4202414,0.3527599,0.0002756752,0.0153049,0.005021243,0.0002483351,0.007266093,0.0138715,0.0004827333,0.02825159,0.0001107345],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904337,0.004712694,0.0005706521,0.0001582723,0.00002460362,0.00087556,0.001481593,0.00003520067,0.00170774],"genre_scores_gemma":[0.9922467,0.001770873,0.0008210968,0.0001776966,0.00003134415,0.0002708948,0.003389587,0.00001287639,0.001278787],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002019685,"threshold_uncertainty_score":0.008295715,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04251350568788086,"score_gpt":0.3952454323940415,"score_spread":0.3527319267061606,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}